Global Anti-Hypertensive Drugs Market Report 2024

AntiHypertensive Drugs Global Market Report 2023 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source( Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Anti Hypertensive Drugs Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke.

The main therapeutics of anti-hypertensive drugs are diuretics, angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, alpha-blockers, calcium channel blockers, renin inhibitors, and vasodilators. Diuretics, also known as water pills, are medications that increase the amount of water and salt excreted by the body in the form of urine. The various sources of diseases include primary hypertension and secondary hypertension, which are treated in hospitals, clinics, and at home care.

The global anti-hypertensive drugs market is segmented -

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

The global anti-hypertensive drugs market size will grow from $37.65 billion in 2022 to $38.70 billion in 2023 at a compound annual growth rate (CAGR) of 2.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anti-hypertensive drugs market size is expected to grow to $41.19 billion in 2027 at a CAGR of 1.6%.

A sedentary lifestyle is a major driver of the growth of the anti-hypertensive drug market. Consumption of junk food, lack of proper healthy and balanced diet, and lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed with hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. Furthermore, in June 2021, according to the World Health Organization data 2021, a Switzerland-based Government agency responsible for international public health, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca PLC., Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, Sun Pharmaceuticals LLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Roche, Abbott, Gilead, Actelion, and Teva Pharmaceutical Industries Ltd.

Low awareness of the antihypertensive drugs amongst the population is one of the major restraints in the anti-hypertensive drugs market. Firstly, most people in developing nations neglect their health checkups and are not aware of their existing hypertension condition in them until they detect extreme symptoms. Secondly, persons diagnosed with hypertension are not adherent to their medication schedule and stop taking medication after 1-2 weeks until symptoms return, thereby posing a huge challenge to the anti-hypertensive drugs market. For example, BMC Research notes published a research survey (from a developing country) which states that out of the total 112 hypertensive subjects with stroke, only 17% of them were adherent to antihypertensive medications. Lack of awareness and low drug adherence restraint the growth of the antihypertensive market.

Of late, there has been a rise in the use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When the two drugs are combined with different mechanisms of action, the effect is two to five times greater than monotherapy. Increasing the dose of monotherapy reduces coronary events by 29% and cerebrovascular events by 40%, while combining two antihypertensive agents with a different mechanism of action reduces coronary events by 40% and cerebrovascular events by 54%. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.

The US Food and Drug Administration (FDA) issued guidance on developing fixed-combination drugs to treat hypertension. This primarily focuses on the clinical development of two-drug combinations of previously approved products. The US FDA expects to see a reduction in adverse effects for combinations that include doses below each drug’s maximum dose compared to single drug regimens at their maximum dose. Earlier physicians typically started a patient on a single drug and titrated up to a maximum dose before adding additional drugs to their program, current guidelines recommend starting patients on two drugs at less than their full doses. Hence, this guidance would keep a check on fixed-combination drugs.

North America was the largest region in the anti-hypertensive drugs market in 2022. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the global anti-hypertensive drugs market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the anti-hypertensive drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The anti-hypertensive drugs market consists of sales of thiazide-type diuretics, beta-blocker metoprolol, olmesartan, and HCTZ. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anti-hypertensive drugs market research report is one of a series of new reports from The Business Research Company that provides anti-hypertensive drugs market statistics, including anti-hypertensive drugs industry global market size, regional shares, competitors with an anti-hypertensive drugs market share, detailed anti-hypertensive drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-hypertensive drugs industry. This anti-hypertensive drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Anti-Hypertensive Drugs Market Characteristics

    3. Anti-Hypertensive Drugs Market Trends And Strategies

    4. Anti-Hypertensive Drugs Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Anti-Hypertensive Drugs Market

    4.2 Ukraine-Russia War Impact On Anti-Hypertensive Drugs Market

    4.3 Impact Of High Inflation On Anti-Hypertensive Drugs Market

    5. Anti-Hypertensive Drugs Market Size And Growth

    5.1. Global Anti-Hypertensive Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Anti-Hypertensive Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Anti-Hypertensive Drugs Market Segmentation

    6.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Diuretics 

    Angiotensin Receptor Blockers (ARBs) 

    Angiotensin Converting Enzyme (ACE) Inhibitors 

    Beta Blockers

    Alpha Blockers

    Calcium Channel Blockers 

    Renin Inhibitors

    Vasodilators

    6.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Primary Hypertension

    Secondary Hypertension

    6.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Clinics

    Homecare

    7. Anti-Hypertensive Drugs Market Regional And Country Analysis

    7.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Anti-Hypertensive Drugs Market

    8.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Anti-Hypertensive Drugs Market

    9.1. China Anti-Hypertensive Drugs Market Overview

    9.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Anti-Hypertensive Drugs Market

    10.1. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Anti-Hypertensive Drugs Market

    11.1. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Anti-Hypertensive Drugs Market

    12.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Anti-Hypertensive Drugs Market

    13.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Anti-Hypertensive Drugs Market

    14.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Anti-Hypertensive Drugs Market

    15.1. Western Europe Anti-Hypertensive Drugs Market Overview

    15.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Anti-Hypertensive Drugs Market

    16.1. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Anti-Hypertensive Drugs Market

    17.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Anti-Hypertensive Drugs Market

    18.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Anti-Hypertensive Drugs Market

    19.1. Eastern Europe Anti-Hypertensive Drugs Market Overview

    19.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Anti-Hypertensive Drugs Market

    20.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Anti-Hypertensive Drugs Market

    21.1. North America Anti-Hypertensive Drugs Market Overview

    21.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Anti-Hypertensive Drugs Market

    22.1. USA Anti-Hypertensive Drugs Market Overview

    22.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Anti-Hypertensive Drugs Market

    23.1. South America Anti-Hypertensive Drugs Market Overview

    23.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Anti-Hypertensive Drugs Market

    24.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Anti-Hypertensive Drugs Market

    25.1. Middle East Anti-Hypertensive Drugs Market Overview

    25.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Anti-Hypertensive Drugs Market

    26.1. Africa Anti-Hypertensive Drugs Market Overview

    26.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles

    27.1. Anti-Hypertensive Drugs Market Competitive Landscape

    27.2. Anti-Hypertensive Drugs Market Company Profiles

    27.2.1. Merck & Co. Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Astra Zeneca Plc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Daiichi Sankyo Company Limited

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Johnson & Johnson Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Pfizer, Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Anti-Hypertensive Drugs Pipeline Analysis

    29. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market

    30. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Merck & Co. Inc. Financial Performance
  • Table 47: Astra Zeneca Plc Financial Performance
  • Table 48: Daiichi Sankyo Company Limited Financial Performance
  • Table 49: Johnson & Johnson Ltd. Financial Performance
  • Table 50: Pfizer, Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Merck & Co. Inc. Financial Performance
  • Figure 47: Astra Zeneca Plc Financial Performance
  • Figure 48: Daiichi Sankyo Company Limited Financial Performance
  • Figure 49: Johnson & Johnson Ltd. Financial Performance
  • Figure 50: Pfizer, Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report